237 related articles for article (PubMed ID: 19899016)
21. [Refractive benefit and incremental costs of LASIK: results of a cost benefit study in two universities' LASIK departments].
Krummenauer F; Roden M; Knorz MC; Dick HB
Klin Monbl Augenheilkd; 2003 May; 220(5):320-5. PubMed ID: 12766820
[TBL] [Abstract][Full Text] [Related]
22. Urinary tract infection in women over the age of 65: is age alone a marker of complication?
Grover ML; Bracamonte JD; Kanodia AK; Edwards FD; Weaver AL
J Am Board Fam Med; 2009; 22(3):266-71. PubMed ID: 19429732
[TBL] [Abstract][Full Text] [Related]
23. Reduction of urinary tract infection and antibiotic use after surgery: a controlled, prospective, before-after intervention study.
Stéphan F; Sax H; Wachsmuth M; Hoffmeyer P; Clergue F; Pittet D
Clin Infect Dis; 2006 Jun; 42(11):1544-51. PubMed ID: 16652311
[TBL] [Abstract][Full Text] [Related]
24. Empiric treatment of uncomplicated UTI in women: wasting money when more is not better.
Kahan NR; Chinitz DP; Waitman DA; Kahan E
J Clin Pharm Ther; 2004 Oct; 29(5):437-41. PubMed ID: 15482387
[TBL] [Abstract][Full Text] [Related]
25. Vaginal mucosal immunization for recurrent urinary tract infection: extended phase II clinical trial.
Uehling DT; Hopkins WJ; Beierle LM; Kryger JV; Heisey DM
J Infect Dis; 2001 Mar; 183 Suppl 1():S81-3. PubMed ID: 11171022
[No Abstract] [Full Text] [Related]
26. Financing in knee arthroplasty: a benchmarking analysis.
Effenberger H; Rehart S; Zumstein MD; Schuh A
Arch Orthop Trauma Surg; 2008 Dec; 128(12):1349-56. PubMed ID: 18309508
[TBL] [Abstract][Full Text] [Related]
27. Childhood vaccination against pneumococcal otitis media and pneumonia: an analysis of benefits and costs.
Weycker D; Richardson E; Oster G
Am J Manag Care; 2000 Jul; 6(10 Suppl):S526-35. PubMed ID: 11183904
[TBL] [Abstract][Full Text] [Related]
28. Recurrent lumbar disc herniation after single-level lumbar discectomy: incidence and health care cost analysis.
Ambrossi GL; McGirt MJ; Sciubba DM; Witham TF; Wolinsky JP; Gokaslan ZL; Long DM
Neurosurgery; 2009 Sep; 65(3):574-8; discussion 578. PubMed ID: 19687703
[TBL] [Abstract][Full Text] [Related]
29. Clinical and economic outcomes of an ambulatory urinary tract infection disease management program.
Armstrong EP
Am J Manag Care; 2001 Mar; 7(3):269-80. PubMed ID: 11258144
[TBL] [Abstract][Full Text] [Related]
30. Changes in composition of IgM polymers in patients suffering from recurrent urinary bacterial infections after bacterial immunization treatment.
Petrušić V; Stojanović M; Zivković I; Inić-Kanada A; Dimitrijević L
Immunol Invest; 2010; 39(8):781-95. PubMed ID: 20718658
[TBL] [Abstract][Full Text] [Related]
31. Active immunoprophyilaxis with uromune® decreases the recurrence of urinary tract infections at three and six months after treatment without relevant secondary effects.
Ramírez Sevilla C; Gómez Lanza E; Manzanera JL; Martín JAR; Sanz MÁB
BMC Infect Dis; 2019 Oct; 19(1):901. PubMed ID: 31660885
[TBL] [Abstract][Full Text] [Related]
32. The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat?
Cai T; Mazzoli S; Mondaini N; Meacci F; Nesi G; D'Elia C; Malossini G; Boddi V; Bartoletti R
Clin Infect Dis; 2012 Sep; 55(6):771-7. PubMed ID: 22677710
[TBL] [Abstract][Full Text] [Related]
33. Disease burden of urinary tract infections among type 2 diabetes mellitus patients in the U.S.
Yu S; Fu AZ; Qiu Y; Engel SS; Shankar R; Brodovicz KG; Rajpathak S; Radican L
J Diabetes Complications; 2014; 28(5):621-6. PubMed ID: 24929797
[TBL] [Abstract][Full Text] [Related]
34. [Immunotherapy and long-term chemoprophylaxis in prevention of recurrent urinary infections in women].
Krcméry S; Hromec J; Gábrisová Z; Tahotný R
Vnitr Lek; 2010 Sep; 56(9 Suppl):955-60. PubMed ID: 21137167
[TBL] [Abstract][Full Text] [Related]
35. Effects of an educational intervention on the rate of recurrent urinary tract infections in selected female outpatients.
Lumsden L; Hyner GC
Women Health; 1985; 10(1):79-86. PubMed ID: 3984360
[TBL] [Abstract][Full Text] [Related]
36. [Clinical practice guidelines. Recurrent infection of the urinary tract in women. Colegio Mexicano de Especialistas en Ginecología y Obstetricia].
Del Pilar Velázquez M; Romero Nava LE; López de Avalos DR; Quiroz Garza G; Solano Sánchez R; Gorbea Chávez V; Iris de la Cruz S; Villagrana Zesatti R; Arredondo García JL; Figueroa Damián R;
Ginecol Obstet Mex; 2010 May; 78(5):S437-59. PubMed ID: 20939242
[No Abstract] [Full Text] [Related]
37. Sublingual Bacterial Vaccination Reduces Recurrent Infections in Patients With Autoimmune Diseases Under Immunosuppressant Treatment.
Sánchez-Ramón S; Fernández-Paredes L; Saz-Leal P; Diez-Rivero CM; Ochoa-Grullón J; Morado C; Macarrón P; Martínez C; Villaverde V; de la Peña AR; Conejero L; Hernández-Llano K; Cordero G; Fernández-Arquero M; Gutierrez BF; Candelas G
Front Immunol; 2021; 12():675735. PubMed ID: 34149711
[TBL] [Abstract][Full Text] [Related]
38. Vaginal treatment with lactic acid gel delays relapses in recurrent urinary tract infections: results from an open, multicentre observational study.
Diebold R; Schopf B; Stammer H; Mendling W
Arch Gynecol Obstet; 2021 Aug; 304(2):409-417. PubMed ID: 33772330
[TBL] [Abstract][Full Text] [Related]
39. Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT).
Wagenlehner F; Wullt B; Ballarini S; Zingg D; Naber KG
Expert Rev Pharmacoecon Outcomes Res; 2018 Feb; 18(1):107-117. PubMed ID: 28737469
[TBL] [Abstract][Full Text] [Related]
40. Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic acid and chondroitin sulphate: a placebo-controlled randomised trial.
Damiano R; Quarto G; Bava I; Ucciero G; De Domenico R; Palumbo MI; Autorino R
Eur Urol; 2011 Apr; 59(4):645-51. PubMed ID: 21272992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
